Nisha Pandey

Groundbreaking Experimental Vaccine May Prevent Pancreatic Cancer From Spreading, Early Trial Finds

In an early trial, scientists are testing the possibility if a vaccine could intercept pancreatic <a href="https://www.healthandme.com/health/cancer">cancer</a>, one of the deadliest cancers in the US, at an early stage and prevent it from becoming invasive.

The trial involves people who were considered at high risk of pancreatic cancer and already had small abnormalities, like cysts, in their pancreas.

The experimental vaccine, called mKRAS-VAX, is designed to train the immune system to recognise mutated KRAS proteins, which are found in most pancreatic ductal adenocarcinomas, the most common type of pancreatic cancer. 

The findings, published in Cancer Discovery, offer an intriguing new approach in which instead of waiting for <a href="https://www.healthandme.com/health-news/one-blood-test-for-multiple-cancers-new-study-shows-promise-in-early-detection-article-155591437" data-type="tilCustomLink">pancreatic cancer</a> to appear and then treating it, researchers are attempting to intercept the disease at its earliest stages.

Also read: <a href="https://www.healthandme.com/health-news/uk-set-to-implement-stricter-prostate-cancer-testing-protocol-which-groups-are-eligible-to-get-tested-article-155692977" data-type="tilCustomLink">UK Set To Implement Stricter Protocol For Prostate Cancer Testing; Who Is Eligible To Get Tested?</a>

Pancreatic cancer often develops gradually from precursor lesions. Some of these lesions can contain mutations in the KRAS gene, which can drive the development of the disease.

The mKRAS-VAX vaccine contains synthetic peptides targeting six common KRAS mutations. The goal is to teach T cells to recognise cells carrying these abnormal proteins and destroy them before they progress into cancer. 

Unlike traditional vaccines against infections, this is a therapeutic <a href="https://www.healthandme.com/health-news/studying-live-cancer-cells-could-transform-drug-discovery-researchers-turn-cell-biology-into-live-cinema-article-155393788" data-type="tilCustomLink">cancer vaccine</a>, meaning it is designed to stimulate the patient's immune system against targets related to cancer.

Also read: <a href="https://www.healthandme.com/health-wellness/gut-bacteria-may-explain-why-western-diets-raise-colon-cancer-risk-study-finds-article-155322854" data-type="tilCustomLink">Following A Western Diet? Changes In Your Gut Bacteria Could Increase Colon Cancer Risk</a>

The Phase 1 study involved 20 people who had either a family history or genetic predisposition to pancreatic cancer and had a pancreatic abnormality detected on imaging.

The vaccine produced mutant-KRAS-specific T-cell responses in 18 of the 20 participants, or 90%. These immune responses persisted for as long as two years. Researchers also saw an intriguing change in pancreatic cysts.

At a median follow-up of 16.5 months, 37.5% of participants experienced cyst reduction or complete resolution. Among a comparable group of unvaccinated people, the figure was 6.8%. 

None of the vaccinated participants had developed <a href="https://www.healthandme.com/health-news/tiktok-star-sydney-towle-dies-at-26-after-three-year-battle-with-rare-bile-duct-cancer-article-155324607" data-type="tilCustomLink">pancreatic ductal adenocarcinoma</a> during the study follow-up. However, this does not prove that the vaccine prevents pancreatic cancer.

The study was small, early-stage and primarily designed to examine safety and whether the vaccine could generate an immune response.

“We are very excited about these results,” pancreatic cancer vaccine researcher Elizabeth Jaffee said.

Male Breast Cancer: The Warning Signs Most Men Don't Know

<a href="https://www.healthandme.com/health-news/who-cancer-agency-flags-3-common-medicines-as-carcinogenic-what-it-means-for-millions-of-patients-article-155300738" data-type="tilCustomLink">Pancreatic cysts</a> are relatively common and most do not become cancerous. But some types can be precursors to pancreatic cancer, which makes them an important for surveillance.

The researchers are interested in whether vaccination could intervene during this window, before malignant cells are formed.

That is particularly significant because pancreatic cancer is notoriously difficult to detect early and remains one of the deadliest cancers.

The long-term ambition is to develop a vaccine to prevent pancreatic cancer but researchers are not there yet.

Jaffee described the field as “nascent” and said she is “cautiously optimistic,” while emphasising that these small Phase 1 studies are not designed to establish whether the vaccines improve survival or prevent cancer. 

Larger Phase 2 studies will be needed to determine whether the early immune responses translate into meaningful clinical benefits. 

Health Conditions A-Z

health

groundbreaking-experimental-vaccine-may-prevent-pancreatic-cancer-from-spreading-early-trial-finds

Pancreatic Cancer

cancer

pancreatic ductal adenocarcinoma

cancer vaccine

Pancreatic cysts

mKRAS VAX vaccine

dr-congo-ebola-outbreak-becomes-deadliest-in-countrys-history-as-death-toll-hits-2325

DR Congo Ebola Outbreak Becomes Deadliest In Country's History As Death Toll Hits 2,325

could-endometriosis-raise-your-risk-of-type-2-diabetes-what-new-study-found

Could Endometriosis Raise Your Risk Of Type 2 Diabetes? What New Study Found

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

In an early trial, scientists are testing the possibility if a vaccine could intercept pancreatic cancer, one of the deadliest cancers in the US, at an early stage and prevent it from becoming invasive. The trial involves people who were considered at high risk of pancreatic cancer and already had small abnormalities, like cysts, in their pancreas.The experimental vaccine, called mKRAS-VAX, is designed to train the immune system to recognise mutated KRAS proteins, which are found in most pancreatic ductal adenocarcinomas, the most common type of pancreatic cancer. The findings, published in Cancer Discovery, offer an intriguing new approach in which instead of waiting for pancreatic cancer to appear and then treating it, researchers are attempting to intercept the disease at its earliest stages.How Does The Vaccine Work?Also read: UK Set To Implement Stricter Protocol For Prostate Cancer Testing; Who Is Eligible To Get Tested?Pancreatic cancer often develops gradually from precursor lesions. Some of these lesions can contain mutations in the KRAS gene, which can drive the development of the disease.The mKRAS-VAX vaccine contains synthetic peptides targeting six common KRAS mutations. The goal is to teach T cells to recognise cells carrying these abnormal proteins and destroy them before they progress into cancer. Unlike traditional vaccines against infections, this is a therapeutic cancer vaccine, meaning it is designed to stimulate the patient's immune system against targets related to cancer.Findings From The Early Trial Also read: Following A Western Diet? Changes In Your Gut Bacteria Could Increase Colon Cancer RiskThe Phase 1 study involved 20 people who had either a family history or genetic predisposition to pancreatic cancer and had a pancreatic abnormality detected on imaging.The vaccine produced mutant-KRAS-specific T-cell responses in 18 of the 20 participants, or 90%. These immune responses persisted for as long as two years. Researchers also saw an intriguing change in pancreatic cysts.At a median follow-up of 16.5 months, 37.5% of participants experienced cyst reduction or complete resolution. Among a comparable group of unvaccinated people, the figure was 6.8%. None of the vaccinated participants had developed pancreatic ductal adenocarcinoma during the study follow-up. However, this does not prove that the vaccine prevents pancreatic cancer.The study was small, early-stage and primarily designed to examine safety and whether the vaccine could generate an immune response.“We are very excited about these results,” pancreatic cancer vaccine researcher Elizabeth Jaffee said. More About Pancreatic Cysts          Pancreatic cysts are relatively common and most do not become cancerous. But some types can be precursors to pancreatic cancer, which makes them an important for surveillance.The researchers are interested in whether vaccination could intervene during this window, before malignant cells are formed.That is particularly significant because pancreatic cancer is notoriously difficult to detect early and remains one of the deadliest cancers.The long-term ambition is to develop a vaccine to prevent pancreatic cancer but researchers are not there yet.Jaffee described the field as “nascent” and said she is “cautiously optimistic,” while emphasising that these small Phase 1 studies are not designed to establish whether the vaccines improve survival or prevent cancer. Larger Phase 2 studies will be needed to determine whether the early immune responses translate into meaningful clinical benefits. 

groundbreaking experimental vaccine may prevent pancreatic cancer from spreading, early trial finds

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Groundbreaking Experimental Vaccine May Prevent Pancreatic Cancer From Spreading, Early Trial Finds

DR Congo Ebola Outbreak Becomes Deadliest In Country's History As Death Toll Hits 2,325

Could Endometriosis Raise Your Risk Of Type 2 Diabetes? What New Study Found

Early Trial Examines A One-Time Treatment That Could Replace Statins To Manage High Cholesterol: Study

Health Conditions A-Z

DR Congo Ebola Outbreak Becomes Deadliest In Country's History As Death Toll Hits 2,325

Groundbreaking Experimental Vaccine May Prevent Pancreatic Cancer From Spreading, Early Trial Finds

Could Endometriosis Raise Your Risk Of Type 2 Diabetes? What New Study Found